• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist


28.035 EUR 0.510 1.85%

As of 02:16:15 ET on 04/16/2014.

Snapshot for Myriad Genetics Inc (MYD)

Open: 28.000 Day's Range: 28.000 - 28.035 Volume: 0
Previous Close: 27.525 52wk Range: 15.025 - 30.495 1-Yr Rtn: +37.43%

Stock Chart for MYD

No chart data available.
  • MYD:GR 28.035
  • 1D
  • 1M
  • 1Y
Interactive MYD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYD

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 17.6216
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2014) 2.1990
Est. PEG Ratio 1.1515
Market Cap (M EUR) 2,045.84
Shares Outstanding (M) 72.97
30 Day Average Volume 392
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYD

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderJames S EvansCFO/Treasurer
Robert Gardner HarrisonChief Information OfficerJerry S LanchburyChief Scientific Officer
More Company Profile & Key Executives for MYD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil